The typical starting dose is 500mg once or twice daily, and dose increases occur gradually until the maximum dose of 2000mg daily is reached
Protagonista, ancora una volta, il farmaco gioiello di Novo Nordisk nato come anti-diabete (di tipo 2) e diventato un successo nella terapia dellobesit , campione di vendite nel primo semestre 2023
In SCI patients and rats, iron deposits in the motor cortex are significantly increased, triggering the accumulation of ROS, and eventually leading to ferroptosis in motor neurons
This makes the medication the first (and currently only) GLP-1 receptor agonist drug approved for kidney treatment
Once those lanes are open, everything else gets easier: thyroid signaling steadies, neurotransmitter balance normalizes, liver pathways clear better, and your other tools finally have leverage